These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Kakefuda K; Fujita Y; Oyagi A; Hyakkoku K; Kojima T; Umemura K; Tsuruma K; Shimazawa M; Ito M; Nozawa Y; Hara H Biochem Biophys Res Commun; 2009 Oct; 387(4):784-8. PubMed ID: 19643082 [TBL] [Abstract][Full Text] [Related]
5. Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulation. Engel N; Mahlknecht U Int J Mol Med; 2008 Feb; 21(2):223-32. PubMed ID: 18204789 [TBL] [Abstract][Full Text] [Related]
6. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Wang C; Chen L; Hou X; Li Z; Kabra N; Ma Y; Nemoto S; Finkel T; Gu W; Cress WD; Chen J Nat Cell Biol; 2006 Sep; 8(9):1025-31. PubMed ID: 16892051 [TBL] [Abstract][Full Text] [Related]
7. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Pallàs M; Pizarro JG; Gutierrez-Cuesta J; Crespo-Biel N; Alvira D; Tajes M; Yeste-Velasco M; Folch J; Canudas AM; Sureda FX; Ferrer I; Camins A Neuroscience; 2008 Jul; 154(4):1388-97. PubMed ID: 18538940 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease. Gan L Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936 [TBL] [Abstract][Full Text] [Related]
13. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. Albani D; Polito L; Forloni G J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622 [TBL] [Abstract][Full Text] [Related]
14. DBC1 is a negative regulator of SIRT1. Kim JE; Chen J; Lou Z Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501 [TBL] [Abstract][Full Text] [Related]
15. SIRT1: tumor promoter or tumor suppressor? Lim CS Med Hypotheses; 2006; 67(2):341-4. PubMed ID: 16546327 [TBL] [Abstract][Full Text] [Related]
16. SIRTUIN 1: regulating the regulator. Zschoernig B; Mahlknecht U Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Law IK; Liu L; Xu A; Lam KS; Vanhoutte PM; Che CM; Leung PT; Wang Y Proteomics; 2009 May; 9(9):2444-56. PubMed ID: 19343720 [TBL] [Abstract][Full Text] [Related]
19. Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation. Suzuki K; Koike T Neuroscience; 2007 Jul; 147(3):599-612. PubMed ID: 17574768 [TBL] [Abstract][Full Text] [Related]
20. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. de Boer VC; de Goffau MC; Arts IC; Hollman PC; Keijer J Mech Ageing Dev; 2006 Jul; 127(7):618-27. PubMed ID: 16603228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]